Nielsen D - Search Results

1

Vaccination with p53 peptide-pulsed dendritic cells is associated with disease stabilization in patients with p53 expressing advanced breast cancer; monitoring of serum YKL-40 and IL-6 as response biomarkers.

Svane IM, Pedersen AE, Johansen JS, Johnsen HE, Nielsen D, Kamby C, Ottesen S, Balslev E, Gaarsdal E, Nikolajsen K, Claesson MH. Svane IM, et al. Among authors: nielsen d. Cancer Immunol Immunother. 2007 Sep;56(9):1485-99. doi: 10.1007/s00262-007-0293-4. Epub 2007 Feb 7. Cancer Immunol Immunother. 2007. PMID: 17285289 Free PMC article. Clinical Trial.

2

Impact of high-dose chemotherapy on antigen-specific T cell immunity in breast cancer patients. Application of new flow cytometric method.

Svane IM, Nikolajsen K, Hansen SW, Kamby C, Nielsen DL, Johnsen HE. Svane IM, et al. Among authors: nielsen dl. Bone Marrow Transplant. 2002 Apr;29(8):659-66. doi: 10.1038/sj.bmt.1703521. Bone Marrow Transplant. 2002. PMID: 12180110

3

[Radiotherapy of primary breast cancer. An analysis of a systematic Cochrane review].

Nielsen DL, Kamby C. Nielsen DL, et al. Ugeskr Laeger. 2003 Jan 13;165(3):219-21. Ugeskr Laeger. 2003. PMID: 12555702 Danish. No abstract available.

4

Vaccination with p53-peptide-pulsed dendritic cells, of patients with advanced breast cancer: report from a phase I study.

Svane IM, Pedersen AE, Johnsen HE, Nielsen D, Kamby C, Gaarsdal E, Nikolajsen K, Buus S, Claesson MH. Svane IM, et al. Among authors: nielsen d. Cancer Immunol Immunother. 2004 Jul;53(7):633-41. doi: 10.1007/s00262-003-0493-5. Epub 2004 Feb 25. Cancer Immunol Immunother. 2004. PMID: 14985857 Free PMC article. Clinical Trial.

5

[High dose chemotherapy versus conventional chemotherapy in metastasing breast cancer. An analysis of a systematic Cochrane review].

Nielsen DL, Svane IM. Nielsen DL, et al. Ugeskr Laeger. 2004 Nov 8;166(46):4145-7. Ugeskr Laeger. 2004. PMID: 15565848 Danish. No abstract available.

6

[High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy in primary breast cancer. An analysis of a systematic Cochrane review].

Nielsen DL, Svane IM. Nielsen DL, et al. Ugeskr Laeger. 2004 Nov 8;166(46):4148-50. Ugeskr Laeger. 2004. PMID: 15565849 Danish. No abstract available.

7

Serum YKL-40, a new prognostic biomarker in cancer patients?

Johansen JS, Jensen BV, Roslind A, Nielsen D, Price PA. Johansen JS, et al. Among authors: nielsen d. Cancer Epidemiol Biomarkers Prev. 2006 Feb;15(2):194-202. doi: 10.1158/1055-9965.EPI-05-0011. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 16492905 Review.

8

[Taxanes in metastatic breast cancer. An analysis of a systematic Cochrane review].

Nielsen DL, Kamby C. Nielsen DL, et al. Ugeskr Laeger. 2006 Sep 11;168(37):3117-20. Ugeskr Laeger. 2006. PMID: 16999914 Review. Danish. No abstract available.

9

[Medical, non-endocrine treatment of metastatic breast cancer--a status].

Lindberg H, Nielsen DL, Kamby C. Lindberg H, et al. Ugeskr Laeger. 2007 Apr 23;169(17):1556-60. Ugeskr Laeger. 2007. PMID: 17484824 Review. Danish.

10

[Neoadjuvant antihormonal treatment of women with breast cancer].

Tuxen MK, Kamby C, Nielsen DL. Tuxen MK, et al. Ugeskr Laeger. 2007 Sep 10;169(37):3077-81. Ugeskr Laeger. 2007. PMID: 17877952 Review. Danish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,531 results

Search Page

Filters